Collectively, these results confirm that PRKAG1 expression level is closely associated with the malignant progression and prognosis of HCC, suggesting that PRKAG1 can serve as an independent prognostic marker for HCC patients. The gene discussed is PRKAG1; the disease is hepatocellular carcinoma.